Steve MacMillan, David LaVance

Hologic President and CEO Steve MacMillan has been appointed chairman of the company's board, following the resignation of David LaVance, who has told the board he will not stand for reelection at the 2016 annual shareholders' meeting. LaVance has been on Hologic's board since 2002.

Additionally, Elaine Ullian, a current director at Hologic, has been appointed the lead independent director. Ullian is the former president and CEO of the Boston Medical Center. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.